The FDA urges manufacturers to revise labeling of transmucosal buprenorphine products to ease access to higher doses because ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
The FDA has banned Red Dye 3 in foods, drinks, and medications. Here’s a list of foods with Red Dye 3, possible health ...
(Off-label use of a drug is when your doctor prescribes a medication ... Here are a few tips that might help guide your discussion: Before your appointment, write down questions such as: How ...
There has been a n irritating shortage of methylphenidate medicines used to treat ADHD as manufacturers struggle to satisfy ...
That's why we created this helpful guide on vitamin B12 to help you learn ... or shot helps you cover all your bases and avoid any drug or nutrient interactions. The information contained ...
Be sure to follow the instructions on the product label. Talk to your healthcare provider before trying new medicinal products. Possible concerns include allergies and sensitivities, drug interactions ...
On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...
Many existing and proposed regulations are now under fire and face rollbacks. But the new administration's pick to lead ...
The US Food and Drug Administration (FDA) has released its proposed rule on front-of-package (FOP) nutrition labeling. Announced on January 14, 2025, the proposed rule would add a requirement to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback